Literature DB >> 6414516

Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase.

G J Roth, E T Machuga, J Ozols.   

Abstract

Aspirin (acetylsalicylic acid) inhibits prostaglandin synthesis by acetylating a single internal serine residue of the initial enzyme in the biosynthetic pathway, prostaglandin synthetase. In this study, the region of the enzyme that is modified by aspirin has been isolated, and its amino acid sequence has been determined. Sheep vesicular gland [acetyl-3H]prostaglandin synthetase was purified following treatment with [acetyl-3H]aspirin and digest with pepsin. An acetyl-3H-labeled peptic peptide of approximately 25 residues was isolated by high-pressure liquid chromatography, and its amino acid sequence was determined to be Ile-Glu-Met-Gly-Ala-Pro-Phe-Ser-Leu-Lys-Gly-Leu-Gly-Asn-Pro-Ile-Glu-Ser-Pro-Glu-Tyr. The acetylated serine residue was located at position 8 in this sequence. The current study marks this polypeptide sequence as a region related to an active site of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6414516     DOI: 10.1021/bi00289a010

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  The eicosanoids and their biochemical mechanisms of action.

Authors:  W L Smith
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

2.  Purification and characterization of sheep platelet cyclo-oxygenase. Acetylation by aspirin prevents haemin binding to the enzyme.

Authors:  R Boopathy; A S Balasubramanian
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

3.  A seven-step plan for becoming a moderately rich and famous biochemist.

Authors:  William L Smith
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

4.  Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors.

Authors:  N Voilley; J de Weille; J Mamet; M Lazdunski
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

5.  Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1.

Authors:  Wen Liu; Elizabeth M Poole; Cornelia M Ulrich; Richard J Kulmacz
Journal:  Pharmacogenet Genomics       Date:  2012-07       Impact factor: 2.089

6.  Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.

Authors:  P T Bozza; J L Payne; S G Morham; R Langenbach; O Smithies; P F Weller
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.

Authors:  E V Negrescu; B Grünberg; M A Kratzer; R Lorenz; W Siess
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

8.  Acetylation of prostaglandin H2 synthases by aspirin is inhibited by redox cycling of the peroxidase.

Authors:  Manju Bala; Cindy N Chin; Asha T Logan; Taneem Amin; Lawrence J Marnett; Olivier Boutaud; John A Oates
Journal:  Biochem Pharmacol       Date:  2007-12-27       Impact factor: 5.858

9.  Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.

Authors:  D L DeWitt; W L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

Review 10.  Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates.

Authors:  L J Marnett
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.